Home » Health » Fluctuating DNA methylation tracks cancer evolution at clinical scale

Fluctuating DNA methylation tracks cancer evolution at clinical scale

by Dr. Michael Lee – Health Editor

New Study links Epigenetic Shifts to⁤ CLL Progression, Offering‍ Potential for Personalized ⁣Prognosis

London, UK – Researchers have uncovered a strong correlation between fluctuating DNA ‌methylation patterns and the clinical course of chronic lymphocytic leukemia (CLL), ‌a ‌common blood cancer. The findings, published today in Nature, suggest that tracking these epigenetic changes could refine risk assessment ​and potentially guide⁣ treatment strategies for patients.The study analyzed data from⁣ 231 CLL patients, tracking absolute lymphocyte counts over time – representing⁣ the number ‌of malignant cells ‌in the blood – and correlating these with ⁢evolutionary variables derived from a computational ⁤model called EVOFLUx. Researchers found that tumor growth‌ rate ‌(θ), effective population size (Ne),⁢ and epigenetic switching rates were all ‌informative of ⁢time ​to frist treatment (TTFT) and ‌overall‌ survival.

Specifically,the‍ growth ⁤rate was‌ analyzed assuming exponential growth (where a θ of 1⁣ equates to a 2.71-fold population increase per ⁢year), Ne ​was considered per million⁣ cells, and cancer age was ‍analyzed in ‍10-year increments. While individual‌ epigenetic switching ​rate parameters (μ,ν,γ,and ζ) proved largely uninformative on thier own,a combined‍ mean epigenetic switching rate – scaled by a⁣ factor of 100 – ‌showed prognostic⁤ value.

Multivariate analysis incorporating growth⁤ rate, effective population size, TP53 aberrations​ (mutations and deletions), IGHV gene mutational status, and patient age at ⁢sampling further ⁤refined the predictive power of these evolutionary variables.Kaplan-Meier​ curves, generated using the maxstats package (v0.7-25) and ​analyzed with the log-rank ‍statistic,demonstrated notable differences in ⁣survival ⁢based on low ​versus high growth rates and effective⁤ population size within⁣ IGHV subtypes.Notably,​ the study ‌compared growth rates estimated by EVOFLUx with those derived from fitting linear models to past lymphocyte count data, validating the computational ‍approach. all ⁢statistical tests were two-sided, and appropriate ‍multiple test ⁤corrections, such as the Holm-Sidak correction, were applied ⁣where ​necessary.The research utilized ⁢R (v4.3.1) with packages Survival‌ (v3.5-7), survminer⁢ (v0.4.9),⁢ ggsurvfit‍ (v0.3.1), and ‌ggplot2 (v3.5.2) for⁣ analysis ‌and⁣ visualization.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.